Susquehanna International Group’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

Susquehanna International Group’s Portfolio PXMD Stock Details PXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,091	Closed	-$13.3K	–	13606
2024 Q1	$13.3K	Buy	+26,091	New	+$15.3K	﹤0.01%	11881
2023 Q4	–	Sell	-1,826	Closed	-$9.22K	–	13711
2023 Q3	$9.22K	Buy	+1,826	New	+$17.7K	﹤0.01%	11728
2023 Q2	–	Sell	-805	Closed	-$26.1K	–	13550
2023 Q1	$26.1K	Buy	+805	New	+$32.3K	﹤0.01%	11964

Other funds holding PXMD

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's PXMD Position: Q2 2024 in Review

Susquehanna International Group sold out of PaxMedica, Inc. Common Stock (PXMD) in Q2 2024, closing a stake of 26,091 shares — an estimated $13.3K sold.

Susquehanna International Group first reported a position in PXMD in Q1 2023 and held it in 3 quarters. The position peaked at $26.1K in Q1 2023. 1 fund tracked by Wall St. Rank holds PXMD as of Q2 2024.

Susquehanna International Group reported no remaining PaxMedica, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 26,091 PaxMedica, Inc. Common Stock shares in Q2 2024, an estimated $13.3K.
Susquehanna International Group first reported a position in PaxMedica, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
Susquehanna International Group's PaxMedica, Inc. Common Stock position peaked at $26.1K in Q1 2023.
1 fund tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.